Hawking, S, Mlodinow, L. The Grand Design. In What is Reality. Bantam Books, USA. 2010.Google Scholar

Steegers, EA, Dadelszen von, P, Duvekot, JJ, Pijnenborg, R. Pre-eclampsia. The Lancet. 2010;376:631–44.CrossRefGoogle ScholarPubMed

Burton, GJ, Woods, AW, Jauniaux, E, Kingdom, JCP. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2010;30:473–82.Google Scholar

Redman, CW, Sargent, IL, Staff, AC. IFPA Senior Award Lecture: Making sense of pre-eclampsia. Placenta. 2014;35:S20–5.Google Scholar

Staff, AC, Redman, CWG. IFPA Award in Placentology Lecture: Preeclampsia, the decidual battleground and future maternal cardiovascular disease. Placenta. 2014;35:S26–S31.CrossRefGoogle ScholarPubMed

Conde-Agudelo, A, Belizán, JM. Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. BJOG. 2000;107:75–83.Google Scholar

Baschat, AA. First-trimester screening for pre-eclampsia: moving from personalized risk prediction to prevention. Ultrasound Obstet Gynecol. 2015;45:119–29.CrossRefGoogle ScholarPubMed

Khan, KS, Wojdyla, D, Say, L, Gulmezoglu, AM, Van Look, PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2005;367:1066–74.Google Scholar

Akolekar, R, Syngelaki, A, Poon, L, Wright, D, Nicolaides, KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33:8–15.Google Scholar

Myatt, L, Redman, CW, Staff, AC, Hansson, S. Strategy for standardization of preeclampsia research study design. Hypertension. 2014;6332(6):1293–301.Google Scholar

Magee, L, Pels, A, Helewa, M, Rey, E, Dadelszen von, P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: Executive Summary. J Obstet Gynaecol Can. 2014;307:416–38.Google Scholar

Oliveira, N, Magder, LS, Blitzer, MG, Baschat, AA. First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort. Ultrasound Obstet Gynecol. 2014;44:279–85.Google Scholar

Poon, LCY, Syngelaki, A, Akolekar, R, Lai, J, Nicolaides, KH. Combined screening for preeclampsia and small for gestational age at 11–13 weeks. Fetal Diagn Ther. 2013;33:16–27.CrossRefGoogle ScholarPubMed

Stampalija T, Monasta L, Di Martino DD, Quadrifoglio M, Lo Bello L, D’Ottavio G, Zullino S, Mastroianni C, Casati D, Signorelli V, Rosti E, Cecotti V, Ceccarello M, Ferrazzi E. The association of first trimester uterine arteries Doppler velocimetry with different clinical phenotypes of hypertensive disorders of pregnancy: a longitudinal study. J Matern Fetal Neonatal Med. 2017 Nov 20:1–9.CrossRefGoogle Scholar

Egbor, M, Ansari, T, Morris, N, Green, CJ, Sibbons, PD. Pre-eclampsia and fetal growth restriction: How morphometrically different is the placenta? Placenta. 2006;27(6–7):727–34.CrossRefGoogle ScholarPubMed

Redline, RW. Placental pathology: a systematic approach with clinical correlations. Placenta. 2008;29 Suppl A:S86–91.Google Scholar

Mayhew, TM, Ohadike, C, Baker, PN, Crocker, IP, Mitchell, C, Ong, SS. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta. 2003;24(2–3):219–26.Google Scholar

Verlohren, S, Melchiorre, K, Khalil, A, Thilaganathan, B. Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia. Ultrasound Obstet Gynecol 2014;44(3):293–8.Google Scholar

Ferrazzi, E, Rigano, S, Padoan, A, Boito, S, Pennati, G, Galan, HL. Uterine artery blood flow volume in pregnant women with an abnormal pulsatility index of the uterine arteries delivering normal or intrauterine growth restricted newborns. Placenta. 2011 Jul 1;32(7):487–92.Google Scholar

Villar, J, Cheick ismail, L, Victoria, CG, Ohuma, EOA, Bertino, E, Altman, DG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet. 2014;384: 857–68.CrossRefGoogle ScholarPubMed

Marconi, AM, Ronzoni, S, Bozzetti, P, Vailati, S, Morabito, A, Battaglia, FC. Comparison of Fetal and Neonatal Growth Curves in Detecting Growth Restriction. Obstet Gynecol. 2008;112:1227–34.Google Scholar

Valensise, H, Vasapollo, B, Gagliardi, G, Novelli, GP. Early and Late Preeclampsia: Two Different Maternal Hemodynamic States in the Latent Phase of the Disease. Hypertension. 2008;52:873–80.CrossRefGoogle ScholarPubMed

Gyselaers, W, Mullens, W, Tomsin, K, Mesens, T, Peeters, L. Role of dysfunctional maternal venous hemodynamics in the pathophysiology of pre-eclampsia: a review. Ultrasound Obstet and Gynecol. 2011;38:123–9.Google Scholar

Melchiorre, K, Sharma, R, Thilaganathan, B. Cardiovascular implications in preeclampsia: an overview. Circulation. 2014;130:703–14.CrossRefGoogle ScholarPubMed

Romundstad, PR, Magnussen, EB, Smith, GD, Vatten, LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation. 2010;122:579–84.Google Scholar

Lisonkova, S, Joseph, KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 2013;209:544–e12.CrossRefGoogle ScholarPubMed

Gyselaers, W. Hemodynamics of the maternal venous compartment: a new area to explore in obstetric ultrasound imaging. Ultrasound Obstet Gynecol. 2008;32:716–7.Google Scholar

Stampalija, T, Casati, D, Ferrazzi, E. et al. Maternal Cardiac Deceleration Capacity: a novel way to explore maternal autonomic function in pregnancies complicated by hypertensive disorders and intrauterine growth restriction. Eur J Obstet Gynecol Reprod Biol.. 2016; 206:6–11.Google Scholar

Ferrazzi, E, Zullino, S, Stampalija, T, et al. Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancy. Ultrasound Obstet Gynecol. 2016;48(2):224–31.CrossRefGoogle ScholarPubMed

Ferrazzi, E, Muggiasca, M, Gervasi, MT. Low molecular weight heparin: does it represent a clinical opportunity for preventing preeclampsia associated with fetal growth restriction? J Matern Fetal Neonatal Med. 2015 Sep;28(13):1525–9.CrossRefGoogle ScholarPubMed

Odibo, AO, Zhong, Y, Goetzinger, KR, et al. First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia. Placenta. 2011;32(8):598–602.Google Scholar

Institute for Health Metrics and Evaluation, US County Profile: Baltimore County, Maryland. Seattle, WA: IHME, 2015Google Scholar

Gziri, MM, Amant, F, Debieve, F, et al. Effects of chemotherapy during pregnancy on the maternal and fetal heart. Prenat Diagn 2012;32:614–19.CrossRefGoogle ScholarPubMed

Mulrooney, DA, Yeazel, MW, Kawashima, T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009;339:b4606.Google Scholar

Trachtenberg, BH, Landy, DC, Franco, VI, et al. Anthracycline-associated cardiotoxicity in survivors of childhood cancer. Pediatr Cardiol 2011;32:342–53.Google Scholar

Telli, ML, Hunt, SA, Carlson, RW, Guardino, AE. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. J Clin Oncol 2007;25:3525–33.Google Scholar

Chien, AJ, Rugo, HS. The cardiac safety of trastuzumab in the treatment of breast cancer. Expert Opin Drug Saf 2010;9:335–46.CrossRefGoogle ScholarPubMed

Sawyer, DB, Peng, X, Chen, B, et al. Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection? Prog Cardiovasc Dis 2010;53:105–13.Google Scholar

Abi Aad, S, Pierce, M, Barmaimon, G, et al. Hypertension induced by chemotherapeutic and immunosuppresive agents: a new challenge. Crit Rev Oncol Hematol 2015;93:28–35.Google Scholar

Ke, AB, Rostami-Hodjegan, A, Zhao, P, Unadkat, JD. Pharmacometrics in pregnancy: An unmet need. Annu Rev Pharmacol Toxicol 2014;54:53–69.Google Scholar

Zhao, Y, Hebert, MF, Venkataramanan, R. Basic obstetric pharmacology. Semin Perinatol 2014;38:475–86.Google Scholar

van Hasselt, JG, van Calsteren, K, Heyns, L, et al. Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel. Ann Oncol 2014;25:2059–65.Google Scholar

Van Calsteren, K, Verbesselt, R, Ottevanger, N, et al. Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand 2010;89:1338–45.Google Scholar

Stensheim, H, Moller, B, van Dijk, T, Fossa, SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 2009;27:45–51.CrossRefGoogle ScholarPubMed

Cardonick, E, Dougherty, R, Grana, G, et al. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J 2010;16:76–82.Google Scholar

Amant, F, von Minckwitz, G, Han, SN, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 2013;31:2532–9.Google Scholar

Loibl, S, Schmidt, A, Gentilini, O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients. JAMA Oncol 2015; 1 (8):1145–53.Google Scholar

Amant, F, Halaska, MJ, Fumagalli, M, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer 2014;24:394–403.Google Scholar

Van Calsteren, K, Heyns, L, De Smet, F, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 2010;28:683–9.CrossRefGoogle ScholarPubMed

Cardonick, E, Iacobucci, A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283–91.Google Scholar

Juonala, M, Cheung, MM, Sabin, MA, et al. Effect of birth weight on life-course blood pressure levels among children born premature: the Cardiovascular Risk in Young Finns Study. J Hypertens 2015;33:1542–8.Google Scholar

Sipola-Leppanen, M, Vaarasmaki, M, Tikanmaki, M, et al. Cardiometabolic risk factors in young adults who were born preterm. Am J Epidemiol 2015;181:861–73.Google Scholar

Siedner, S, Kruger, M, Schroeter, M, et al. Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J Physiol 2003;548:493–505.Google Scholar

Rudolph, AM. Myocardial growth before and after birth: clinical implications. Acta Paediatr 2000;89:129–33.Google ScholarPubMed

Germann, N, Goffinet, F, Goldwasser, F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 2004;15:146–50.Google Scholar

Achtari, C, Hohlfeld, P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am J Obstet Gynecol 2000;183:511–12.Google Scholar

Reynoso, EE, Huerta, F. Acute leukemia and pregnancy–fatal fetal outcome after exposure to idarubicin during the second trimester. Acta Oncol 1994;33:709–10.Google ScholarPubMed

Baumgartner, AK, Oberhoffer, R, Jacobs, VR, et al. Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML. Onkologie 2009;32:40–3.Google Scholar

Gziri, MM, Debieve, F, De Catte, L, et al. Chemotherapy during pregnancy: effect of anthracyclines on fetal and maternal cardiac function. Acta Obstet Gynecol Scand 2012;91:1465–8.Google Scholar

Meyer-Wittkopf, M, Barth, H, Emons, G, Schmidt, S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol 2001;18:62–6.Google Scholar

Amant, F, Vandenbroucke, T, Verheecke, M, et al. Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med 2015; 373(19):1824–34.Google Scholar

Aviles, A, Neri, N, Nambo, MJ. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol 2006;17:286–8.Google Scholar

Gziri, MM, Hui, W, Amant, F, et al. Myocardial function in children after fetal chemotherapy exposure. A tissue Doppler and myocardial deformation imaging study. Eur J Pediatr 2013;172:163–70.Google Scholar

Van Calsteren, K, Verbesselt, R, Beijnen, J, et al. Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol 2010;119:594–600.Google Scholar

Grohard, P, Akbaraly, JP, Saux, MC, et al. Transplacental passage of doxorubicin. J Gynecol Obstet Biol Reprod (Paris) 1989;18:595–600.Google Scholar

Gaillard, B, Leng, JJ, Grellet, J, et al. Transplacental passage of epirubicin. J Gynecol Obstet Biol Reprod (Paris) 1995;24:63–8.Google Scholar

Pearson, GD, Veille, JC, Rahimtoola, S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183–8.Google Scholar

van Dalen, EC, van der Pal, HJ, van den Bos, C, et al. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines. Eur J Cancer 2006;42:2549–53.Google Scholar

Krischer, JP, Epstein, S, Cuthbertson, DD, et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol 1997;15:1544–52.Google Scholar

Silber, JH, Jakacki, RI, Larsen, RL, et al. Increased risk of cardiac dysfunction after anthracyclines in girls. Med Pediatr Oncol 1993;21:477–9.CrossRefGoogle ScholarPubMed

Katz, A, Goldenberg, I, Maoz, C, et al. Peripartum cardiomyopathy occurring in a patient previously treated with doxorubicin. Am J Med Sci 1997;314:399–400.Google Scholar

Bar, J, Davidi, O, Goshen, Y, et al. Pregnancy outcome in women treated with doxorubicin for childhood cancer. Am J Obstet Gynecol 2003;189:853–7.Google Scholar

Hines, MR, Mulrooney, DA, Hudson, MM, et al. Pregnancy-associated cardiomyopathy in survivors of childhood cancer. J Cancer Surviv 2016;10(1):113–21.Google Scholar

Altena, R, Gietema, JA, van Veldhuisen, DJ, Reyners, AK. Pregnancy unbosoms the heart of breast cancer survivors. Ann Oncol 2012;23:2206–8.Google Scholar

European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.Google Scholar

Magnussen, EB, Vatten, LJ, Lund-Nilsen, TI, Salvesen, KA, Davey Smith, G, Romundstad, PR. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ 2007;335:978.Google Scholar

Spiegelberg, O. The pathology and treatment of puerperal eclampsia. Trans Am Gynecol Soc 1878;2:161–74.Google Scholar

Chesley, LC. History and epidemiology of preeclampsia-eclampsia. Clin Obstet Gynecol 1984;27:801–20.Google Scholar

Chesley, LC, Annitto, JE, Cosgrove, RA. The remote prognosis of eclamptic women. Sixth periodic report. Am J Obstet Gynecol 1976;124:446–59.Google Scholar

Williams, GC. Pleiotropy, natural selection, and the evolution of senescence. Evolution 1957;11:635–32.Google Scholar

Kirkwood, TBL. Evolution of aging. Nature 1977;270:301–4.Google Scholar

Ness, RB, Harris, T, Cobb, J. et al. Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med 1993;328:1528–33.Google Scholar

Parikh, NI, Cnattingius, S, Dickman, PW, Mittleman, MA, Ludvigsson, JF, Ingelsson, E. Parity and risk of later-life maternal cardiovascular disease. Am Heart J 2010;159:215–221.Google Scholar

Kuningas, M, Altmäe, S, Uitterlinden, AG, Hofman, A, van Duijn, CM, Tiemeier, H. The relationship between fertility and lifespan in humans. Age (Dordr) 2011;33:615–22.CrossRefGoogle ScholarPubMed

Grundy, EM, Tomassini, C. Marital history, health and mortality among older men and women in England and Wales. BMC Public Health 2010;10:554.Google Scholar

Grundy, E, Tomassini, C. Fertility history and health in later life: a record linkage study in England and Wales. Soc Sci Med 2005;61:217–28.Google Scholar

Grundy, E, Kravdal, Ø. Do short birth intervals have long-term implications for parental health? Results from analyses of complete cohort Norwegian register data. J Epidemiol Community Health 2014;68:958–64.Google Scholar

Ngo, AD, Roberts, CL, Figtree, G. Association between interpregnancy interval and future risk of maternal cardiovascular disease—a population-based record linkage study. BJOG 2016;123(8):1311–8.Google Scholar

Conde-Agudelo, A, Belizán, JM. Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study. BMJ 2000;321:1255–9.Google Scholar

Smith, GN, Pudwell, J, Roddy, M. The Maternal Health Clinic: a new window of opportunity for early heart disease risk screening and intervention for women with pregnancy complications. J Obstet Gynaecol Can 2013;35:831–9.Google Scholar

Sattar, N, Greer, IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002;20;325(7356):157–60.Google Scholar

Mosca, L, Benjamin, EJ, Berra, K, et al. American Heart Association. Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: a guideline from the American Heart Association. J Am Coll Cardiol 2011; 57:1404–23.Google Scholar

Cirillo, PM, Cohn, BA. Pregnancy complications and cardiovascular disease death: 50-year follow-up of the Child Health and Development Studies pregnancy cohort. Circulation 2015;132:1234–42.CrossRefGoogle ScholarPubMed

Berks, D, Hoedjes, M, Raat, H, Duvekot, JJ, Steegers, EA, Habbema, JD. Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: a literature-based study. BJOG 2013;120:924–31.Google Scholar

Burgess, A, Founds, S. Cardiovascular implications of preeclampsia. MCN Am J Matern Child Nurs 2016;41:8–15.Google Scholar

Charlton, F, Tooher, J, Rye, KA, Hennessy, A. Cardiovascular risk, lipids and pregnancy: preeclampsia and the risk of later life cardiovascular disease. Heart Lung Circ 2014;623:203–12.Google Scholar

Bellamy, L, Casas, JP, Hingorani, AD, Williams, DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335(7627):974.Google Scholar

Berks, D, Steegers, EA, Molas, M, Visser, W. Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol 2009;114:1307–14.CrossRefGoogle ScholarPubMed

Ferrazzani, S, De Carolis, S, Pomini, F, Testa, AC, Mastromarino, C, Caruso, A. The duration of hypertension in the puerperium of preeclamptic women: relationship with renal impairment and week of delivery. Am J Obstet Gynecol 1994 171:506–12.Google Scholar

Scantlebury, DC, Kane, GC, Wiste, HJ, et al. Left ventricular hypertrophy after hypertensive pregnancy disorders. Heart 2015;101:1584–90.CrossRefGoogle ScholarPubMed

Ghossein-Doha, C, Peeters, L, van Heijster, S, van Kuijk, S, Spaan, J, Delhaas, T, Spaanderman, M. Hypertension after preeclampsia is preceded by changes in cardiac structure and function. Hypertension 2013;62:382–90.CrossRefGoogle ScholarPubMed

Melchiorre, K, Sutherland, GR, Liberati, M, Thilaganathan, B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension 2011;58:709–15.Google Scholar

Ray, JG, Vermeulen, MJ, Schull, MJ, Redelmeier, DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005;366(9499):1797–803.Google Scholar

Wilson, BJ, Watson, MS, Prescott, GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003;326(7394):845.Google Scholar

Wikström, AK, Haglund, B, Olovsson, M, Lindeberg, SN. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG 2005;112:1486–91.Google Scholar

Lykke, JA, Langhoff-Roos, J, Sibai, BM, Funai, EF, Triche, EW, Paidas, MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009;53:944–51.Google Scholar

Lin, YS, Tang, CH, Yang, CY, et al. Effect of pre-eclampsia-eclampsia on major cardiovascular events among peripartum women in Taiwan. Am J Cardiol 2011;107:325–30.Google Scholar

Irgens, HU, Reisaeter, L, Irgens, LM, Lie, RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001;24;323(7323):1213–7.Google Scholar

Mongraw-Chaffin, ML, Cirillo, PM, Cohn, BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 2010;56:166–71.CrossRefGoogle ScholarPubMed

Cirillo, PM, Cohn, BA. Pregnancy complications and cardiovascular disease death: 50-year follow-up of the Child Health and Development Studies pregnancy cohort. Circulation 2015;132:1234–42.Google Scholar

Skjaerven, R, Wilcox, AJ, Klungsøyr, K, et al. Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study. BMJ 2012;345:e7677.Google Scholar

Sibai, BM, el-Nazer, A, Gonzalez-Ruiz, A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986;155:1011–16.Google Scholar

Catov, JM, Lewis, CE, Lee, M, Wellons, MF, Gunderson, EP. Preterm birth and future maternal blood pressure, inflammation, and intimal-medial thickness: the CARDIA study. Hypertension 2013;61:641–6.Google Scholar

Perng, W, Stuart, J, Rifas-Shiman, SL, Rich-Edwards, JW, Stuebe, A, Oken, E. Preterm birth and long-term maternal cardiovascular health. Ann Epidemiol 2015;25:40–5.Google Scholar

Xu, J, Barinas-Mitchell, E, Kuller, LH, Youk, AO, Catov, JM. Maternal hypertension after a low-birth-weight delivery differs by race/ethnicity: evidence from the National Health and Nutrition Examination Survey (NHANES) 1999–2006. PLoS One 2014;9:e104149.Google Scholar

Bonamy, AK, Parikh, NI, Cnattingius, S, Ludvigsson, JF, Ingelsson, E. Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth. Circulation 2011;124:2839–46.Google Scholar

Kessous, R, Shoham-Vardi, I, Pariente, G, Holcberg, G, Sheiner, E. An association between preterm delivery and long-term maternal cardiovascular morbidity. Am J Obstet Gynecol 2013;209:368.e1–8.CrossRefGoogle ScholarPubMed

Smith, GC, Pell, JP, Walsh, D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001;357(9273):2002–6.Google Scholar

Stergiotou, I, Bijnens, B, Cruz-Lemini, M, Figueras, F, Gratacós, E, Crispi, F. Maternal subclinical vascular changes in fetal growth restriction with and without pre-eclampsia. Ultrasound Obstet Gynecol 2015;46:706–12.Google Scholar

Lind, JM, Hennessy, A, McLean, M. Cardiovascular disease in women: the significance of hypertension and gestational diabetes during pregnancy. Curr Opin Cardiol 2014;29:447–53.Google Scholar

Retnakaran, R, Shah, BR. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population‐based cohort study. CMAJ 2009;181:371–6.Google Scholar

Shah, BR, Retnakaran, R, Booth, GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care 2008;31:1668–9.Google Scholar

Goueslard, K, Cottenet, J, Mariet, AS, et al. Early cardiovascular events in women with a history of gestational diabetes mellitus. Cardiovasc Diabetol 2016;15:15.Google Scholar

Li, JW, He, SY, Liu, P, Luo, L, Zhao, L, Xiao, YB. Association of gestational diabetes mellitus (GDM) with subclinical atherosclerosis: a systemic review and meta-analysis. BMC Cardiovasc Disord 2014;14:132.Google Scholar

DeRoo, L, Skjærven, R, Wilcox, A, Klungsøyr, K, Wikström, AK, Morken, NH, Cnattingius, S. Placental abruption and long-term maternal cardiovascular disease mortality: a population-based registry study in Norway and Sweden. Eur J Epidemiol 2015 Jul 16.31(5):501–11.Google Scholar

Lykke, JA, Langhoff-Roos, J, Lockwood, CJ, Triche, EW, Paidas, MJ. Mortality of mothers from cardiovascular and non-cardiovascular causes following pregnancy complications in first delivery. Paediatr Perinat Epidemiol 2010;24:323–30.Google Scholar

Pariente, G, Shoham-Vardi, I, Kessous, R, Sherf, M, Sheiner, E. Placental abruption as a significant risk factor for long-term cardiovascular mortality in a follow-up period of more than a decade. Paediatr Perinat Epidemiol 2014;28:32–8.Google Scholar

Wagner, MM, Bhattacharya, S, Visser, J, Hannaford, PC, Bloemenkamp, KW. Association between miscarriage and cardiovascular disease in a Scottish cohort. Heart 2015;101:1954–60.CrossRefGoogle Scholar

Oliver-Williams, CT, Heydon, EE, Smith, GC, Wood, AM. Miscarriage and future maternal cardiovascular disease: a systematic review and meta-analysis. Heart 2013;99:1636–44.Google Scholar

Ranthe, MF, Andersen, EA, Wohlfahrt, J, Bundgaard, H, Melbye, M, Boyd, HA. Pregnancy loss and later risk of atherosclerotic disease. Circulation 2013;127:1775–82.Google Scholar

McClure, CK, Catov, JM, Ness, R, Bodnar, LM. Associations between gestational weight gain and BMI, abdominal adiposity, and traditional measures of cardiometabolic risk in mothers 8 y postpartum. Am J Clin Nutr 2013;98:1218–25.Google Scholar

Walter, JR, Perng, W, Kleinman, KP, Rifas-Shiman, SL, Rich-Edwards, JW, Oken, E. Associations of trimester-specific gestational weight gain with maternal adiposity and systolic blood pressure at 3 and 7 years postpartum. Am J Obstet Gynecol 2015;212(499):e1–12.Google Scholar

Lee, KK, Raja, EA, Lee, AJ, et al. Maternal obesity during pregnancy associates with premature mortality and major cardiovascular events in later life. Hypertension 2015;66:938–44.Google Scholar

Gratacós, E, Casals, E, Gómez, O, et al. Increased susceptibility to low density lipoprotein oxidation in women with a history of pre-eclampsia. BJOG 2003;110:400–4.Google Scholar

Thadhani, R, Ecker, JL, Mutter, WP, et al. Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia. Hypertension 2004; 43:988–92.Google Scholar

Al-Nasiry, S, Ghossein-Doha, C, Polman, SE, et al. Metabolic syndrome after pregnancies complicated by pre-eclampsia or small-for-gestational-age: a retrospective cohort. BJOG 2015; 122:1818–23.Google Scholar

Östlund, E, Al-Nashi, M, Hamad, RR, et al. Normalized endothelial function but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia. Hypertens Res 2013; 36:1081–7.Google Scholar

Yinon, Y, Kingdom, JC, Odutayo, A, et al. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk. Circulation 2010;122:1846–53.Google Scholar

Sandvik, MK, Leirgul, E, Nygård, O, et al. Preeclampsia in healthy women and endothelial dysfunction 10 years later. Am J Obstet Gynecol 2013;209:569.e1–569.e10.Google Scholar

Hoedjes, M, Berks, D, Vogel, I, et al. Motivators and barriers to a healthy postpartum lifestyle in women at increased cardiovascular and metabolic risk: a focus-group study. Hypertens Pregnancy 2012;31:147–55.Google Scholar

Smith, GN. The Maternal Health Clinic: Improving women’s cardiovascular health. Semin Perinatol 2015;39:316–9.Google Scholar

Janmohamed, R, Montgomery-Fajic, E, Sia, W, et al. Cardiovascular risk reduction and weight management at a hospital-based postpartum preeclampsia clinic. J Obstet Gynaecol Can 2015;37:330–7.Google Scholar

Scholten, RR, Thijssen, DJ, Lotgering, FK, Hopman, MT, Spaanderman, ME. Cardiovascular effects of aerobic exercise training in formerly preeclamptic women and healthy parous control subjects. Am J Obstet Gynecol 2014;211:516.e1–516.e11.Google Scholar

Rich-Edwards, JW, Fraser, A, Lawlor, DA, Catov, JM. Pregnancy characteristics and women’s future cardiovascular health: an underused opportunity to improve women’s health? Epidemiol Rev 2014; 36:57–70.Google Scholar

Yusuf, S, Hawken, S, Ounpuu, S, et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364(9438):937–52.Google Scholar

Umans-Eckenhausen, MA, Sijbrands, EJ, Kastelein, JJ, Defesche, JC. Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation 2002;106:3031–6.Google Scholar

Parikh, NI, Cnattingius, S, Dickman, PW, Mittleman, MA, Ludvigsson, JF, Ingelsson, E. Parity and risk of later-life maternal cardiovascular disease. Am Heart J 2010; 159:215–221.e6).Google Scholar

Kuningas, M, Altmäe, S, Uitterlinden, AG, Hofman, A, van Duijn, CM, Tiemeier, H. The relationship between fertility and lifespan in humans. Age (Dordr) 2011; 33:615–22.Google Scholar

Ngo, AD, Roberts, CL, Figtree, G. Association between interpregnancy interval and future risk of maternal cardiovascular disease – a population-based record linkage study. BJOG 2015 Oct 20.Google Scholar

Sattar, N, Greer, IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002; 20;325(7356):157–60.Google Scholar

Bellamy, L, Casas, JP, Hingorani, AD, Williams, DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335(7627):974.Google Scholar

Bellamy, L, Casas, JP, Hingorani, AD, Williams, DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335(7627):974.Google Scholar

Irgens, HU, Reisaeter, L, Irgens, LM, Lie, RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001 24;323(7323):1213–17.Google Scholar

Skjaerven, R, Wilcox, AJ, Klungsøyr, K, Irgens, LM, Vikse, BE, Vatten, LJ, Lie, RT. Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study. BMJ 2012; 345:e7677.Google Scholar